Impairment of MCP-1 expression in mesothelial cells exposed to peritoneal dialysis fluid by osmotic stress and acidic stress

Peritoneal Dialysis International

Volumn 31, Issue 1, 2011, Pages 80-89

  Ogata, Ryouji ^a   Hiramatsu, Nobuhiko ^a   Hayakawa, Kunihiro ^a   Nakajima, Shotaro ^a   Yao, Jian ^a   Kobayashi, Tetsuro ^a   Kitamura, Masanori ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

MCP 1; Mesothelial cell; MKP 1; NF B; p38 MAP kinase; Peritoneal dialysis fluid

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PERITONEAL DIALYSIS FLUID; DIALYSIS FLUID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CELL STRESS; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPEROSMOLALITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESOTHELIUM CELL; MOUSE; NONHUMAN; OSMOTIC STRESS; PERITONEAL DIALYSIS; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; EPITHELIUM CELL; MONOCYTE; OSMOSIS; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MONOCYTES; OSMOSIS; STRESS, PHYSIOLOGICAL;

EID: 84855161359     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00159     Document Type: Article

References (41)

1. Nolph KD, Cutler SJ, Steinberg SM, Novak JW. Continuous ambulatory peritoneal dialysis in the United States: a three-year study. Kidney Int 1985; 28:198-205.
2. Miyazaki M, Yuzawa Y. The role of peritoneal fibrosis in encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S48-56.
3. Robson RL, McLoughlin RM, Witowski J, Loetscher P, Wilkinson TS, Jones SA, et al. Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-controls neutrophil migration across the mesothelium in vitro and in vivo. J Immunol 2001; 167: 1028-38.
4. Sach M, Loetscher P, Burger JA, Knopf HP, Schollmeyer P, Dobos GJ. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages. Adv Perit Dial 1995; 11:19-23.
5. Sach M, Bauermeister K, Burger JA, Loetscher P, Elsner J, Schollmeyer P, et al. Inverse MCP-1/IL-8 ratio in effluents of CAPD patients with peritonitis and in isolated cultured human peritoneal macrophages. Nephrol Dial Transplant 1997; 12:315-20.
6. Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int 1996; 50(Suppl 56): S17-21.
7. Shyy YJ, Li YS, Kolattukudy PE. Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem Biophys Res Commun 1990; 169:346-51.
8. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, et al. NF-B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153:2052-63.
9. Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, et al. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 2004; 15:1289-99.
10. Lee SK, Kim BS, Yang WS, Kim SB, Park SK, Park JS. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int 2001; 60:55-64.
11. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996; 74:589-607.
12. Breborowicz A, Oreopoulos DG. Biocompatibility of peritoneal dialysis solutions. Am J Kidney Dis 1996; 27: 738-43.
13. Topley N. Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions. Adv Ren Replace Ther 1998; 5:179-84.
14. Jorres A, Williams JD, Topley N. Peritoneal dialysis solution biocompatibility: inhibitory mechanisms and recent studies with bicarbonate-buffered solutions. Perit Dial Int 1997; 17(Suppl 2):S42-6.
15. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
16. Douvdevani A, Abramson O, Tamir A, Konforty A, Isakov N, Chaimovitz C. Commercial dialysate inhibits TNF-mRNA expression and NF-B DNA-binding activity in LPSstimulated macrophages. Kidney Int 1995; 47:1537-45.
17. Duncan EL, Whitaker NJ, Moy EL, Reddel RR. Assignment of SV40-immortalized cells to more than one complementation group for immortalization. Exp Cell Res 1993; 205: 337-44.
18. Hjelle JT, Golinska BT, Waters DC, Steidley KR, McCarroll DR, Dobbie JW. Isolation and propagation in vitro of peritoneal mesothelial cells. Perit Dial Int 1989; 9:341-7.
19. Hiramatsu N, Kasai A, Hayakawa K, Yao J, Kitamura M. Real-time detection and continuous monitoring of ER stress in vitro and in vivo by ES-TRAP: evidence for systemic, transient ER stress during endotoxemia. Nucleic Acids Res 2006; 34:e93.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
21. Kitamura M, Taylor S, Unwin R, Burton S, Shimizu F, Fine LG. Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J Clin Invest 1994; 94:497-505.
22. Kitamura M, Sütö T, Yokoo T, Shimizu F, Fine LG. Transforming growth factor-1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J Immunol 1996; 156: 2964-71.
23. Klinkenberg M, Van Huffel S, Heyninck K, Beyaert R. Functional redundancy of the zinc fingers of A20 for inhibition of NF-B activation and protein-protein interactions. FEBS Lett 2001; 498:93-7.
24. Bezy O, Elabd C, Cochet O, Petersen RK, Kristiansen K, Dani C, et al. Delta-interacting protein A, a new inhibitory partner of CCAAT/enhancer-binding protein, implicated in adipocyte differentiation. J Biol Chem 2005; 280:11432-8.
25. Bennett AM, Tonks NK. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997; 278:1288-91.
26. Hayakawa K, Meng Y, Hiramatsu N, Kasai A, Yamauchi K, Yao J, et al. Priming of glomerular mesangial cells by activated macrophages causes blunted responses to proinflammatory stimuli. J Immunol 2006; 176:2529-37.
27. Hayakawa K, Hiramatsu N, Okamura M, Yamazaki H, Nakajima S, Yao J, et al. Acquisition of anergy to proinflammatory cytokines in non-immune cells through endoplasmic reticulum stress response: a mechanism for subsidence of inflammation. J Immunol 2009; 182: 1182-91.
28. 2-induced apoptosis via MAP kinase-MKP-1 pathway. Free Radic Biol Med 2004; 36:985-93.
29. Rovin BH, Dickerson JA, Tan LC, Hebert CA. Activation of nuclear factor-B correlates with MCP-1 expression by human mesangial cells. Kidney Int 1995; 48:1263-71.
30. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-B sites and NF-B/Rel subunit specificity. J Biol Chem 1997; 272: 31092-9.
31. Jesenberger V, Jentsch S. Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol 2002; 3:112-21.
32. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, Hauser S, et al. A selective IKK-2 inhibitor blocks NF-Bdependent gene expression in IL-1-stimulated synovial fibroblasts. J Biol Chem 2003; 278:32861-71.
33. Du S, Hiramatsu N, Hayakawa K, Kasai A, Okamura M, Huang T, et al. Suppression of NF-B by cyclosporine A and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol 2009; 182:7201-11.
34. Okamura M, Takano Y, Hiramatsu N, Hayakawa K, Yao J, Paton AW, et al. Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response. Am J Physiol Renal Physiol 2008; 295:F1495-F1503.
35. Roebuck KA, Carpenter LR, Lakshminarayanan V, Page SM, Moy JN, Thomas LL. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-B. J Leukoc Biol 1999; 65:291-8.
36. Xu ZG, Kim KS, Park HC, Choi KH, Lee HY, Han DS, et al. High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells. Kidney Int 2003; 63: 958-68.
37. Matsuo H, Tamura M, Kabashima N, Serino R, Tokunaga M, Shibata T, et al. Prednisolone inhibits hyperosmolalityinduced expression of MCP-1 via NF-B in peritoneal mesothelial cells. Kidney Int 2006; 69:736-46.
38. Duzgun SA, Rasque H, Kito H, Azuma N, Li W, Basson MD, et al. Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions. J Cell Biochem 2000; 76:567-71.
39. Bode JG, Gatsios P, Ludwig S, Rapp UR, Häussinger D, Heinrich PC, et al. The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolality. J Biol Chem 1999; 274:30222-7.
40. Schliess F, Heinrich S, Häussinger D. Hyperosmotic induction of the mitogen-activated protein kinase phosphatase MKP-1 in H4IIE rat hepatoma cells. Arch Biochem Biophys 1998; 351:35-40.
41. Xu L, Fidler IJ. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res 2000; 60:4610-16.